Catalyst Pharmaceuticals Competitors and Similar CompaniesClear all

Alnylam's competitors and similar companies include ANI Pharmaceuticals and Olpha.

	Alnylam Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.	ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.	Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
Founding Date	Founding Date 2002	Founding Date 1996	Founding Date 1972
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare drug development pharma
Locations	Locations Cambridge, US HQ Paris, FR Milan, IT Tokyo, JP Amsterdam, NL Stockholm, SE Zug, CH see more	Locations Baudette, US HQ Oakville, CA Baudette, US	Locations Olaine, LV HQ
Employees	Employees 1,32324% increase	Employees 33813% increase	Employees 2,191
Valuation ($)	Valuation ($) 36.5 b	Valuation ($) 1.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $3.7b (FY, 2025)	Revenue (est.) $883.4m (FY, 2025)	Revenue (est.) €122.2m (FY, 2020)
Cost of goods	Cost of goods $677.2m (FY, 2025)	Cost of goods N/A	Cost of goods €44.5m (FY, 2020)
Gross profit	Gross profit $3b (FY, 2025)	Gross profit N/A	Gross profit €80.1m (FY, 2020)
Net income	Net income $313.7m (FY, 2025)	Net income N/A	Net income €9.5m (FY, 2020)